Literature DB >> 2506274

Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts.

H L Shear1, R Srinivasan, T Nolan, C Ng.   

Abstract

IFN-gamma plays an important role in host defense against microbial disease. Here, we studied the role of IFN-gamma in lethal and nonlethal murine malaria. Administration of recombinant murine IFN-gamma resulted in a dose-dependent protection of SW, BALB/cByJ, and CBA/J mice from the lethal variant of Plasmodium yoelii 17x (PyL) but had little effect on the course of the nonlethal variant of this parasite (PyNL). Administration of recombinant IFN-gamma also resulted in the activation of peritoneal macrophages for increased phagocytosis of malaria-infected erythrocytes and release of H2O2, as measured in vitro. The ability of spleen cells from infected mice to produce endogenous IFN-gamma and release H2O2 during the course of malaria was also studied. In BALB/cByJ mice, which are relatively susceptible to PyL and PyNL, there was an initial burst of IFN-gamma only in response to PyNL whereas in CBA/J mice, which are relatively resistant to these parasites, there was an initial burst of IFN-gamma in response to both PyL and PyNL. The kinetics of H2O2 release corresponded to that of IFN-gamma. In all infections, levels of IFN-gamma declined as parasitemia increased; however, nonlethal infections were characterized by a recovery of both IFN-gamma activity and H2O2 release as parasitemia declined. These data suggest that IFN-gamma may play an important role in modulating the course of malaria infections by activating macrophages for both intracellular and extracellular parasite destruction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506274

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.

Authors:  M Troye-Blomberg; E M Riley; L Kabilan; M Holmberg; H Perlmann; U Andersson; C H Heusser; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.

Authors:  R Harpaz; R Edelman; S S Wasserman; M M Levine; J R Davis; M B Sztein
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

4.  Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.

Authors:  Bo Huang; Man Liu; Shiguang Huang; Bin Wu; Hong Guo; Xin-Zhuan Su; Fangli Lu
Journal:  Parasitol Res       Date:  2013-05-08       Impact factor: 2.289

5.  Macrophages expressing heat-shock protein 65 play an essential role in protection of mice infected with Plasmodium yoelii.

Authors:  M Zhang; H Hisaeda; T Sakai; H Ishikawa; Y P Hao; Y Nakano; Y Ito; K Himeno
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

6.  Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.

Authors:  Kathleen R Page; Anne E Jedlicka; Benjamin Fakheri; Gregory S Noland; Anup K Kesavan; Alan L Scott; Nirbhay Kumar; Yukari C Manabe
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa.

Authors:  A Ishih; T Nagata; F Kobayashi; T Miyase; M Terada
Journal:  Parasitol Res       Date:  2004-08-26       Impact factor: 2.289

8.  Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice.

Authors:  Martha Legorreta-Herrera; Rodrigo Oviedo Meza; Leticia Moreno-Fierros
Journal:  J Biomed Biotechnol       Date:  2010-03-11

9.  Cellular mechanisms in the immune response to malaria in Plasmodium vinckei-infected mice.

Authors:  H Perlmann; S Kumar; J M Vinetz; M Kullberg; L H Miller; P Perlmann
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  An early burst of IFN-gamma induced by the pre-erythrocytic stage favours Plasmodium yoelii parasitaemia in B6 mice.

Authors:  Valérie Soulard; Jacques Roland; Olivier Gorgette; Eliane Barbier; Pierre-André Cazenave; Sylviane Pied
Journal:  Malar J       Date:  2009-06-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.